Netherlands· NL-d820f9cdd4bc

Nalador-500, poeder voor oplossing voor infusie 500 mcg

A sulproston product containing sulproston, registered in Netherlands by BModesto B.V.. The same ATC class is registered in 4 of our 19 countries.

ATC G02AD05

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about sulprostonAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Sulproston is registered in 4 of 19 countries.

Countries holding a registration under ATC G02AD05 (sulproston), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
3 of them publish a price we can compare per daily dose

Search sulproston products by name

Sulproston · ATC G02AD05

4 / 19 countries

Finlandprice
Franceprice
Netherlands
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: SULPROSTON
Manufacturer: BModesto B.V.
Country: Netherlands (NL)
ATC code: G02AD05
ATC class: Sulproston
Defined daily dose: 0.5 mg, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
132971//08996

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sulproston in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sulproston products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

Austria · Nalador
Germany · Nalador-500
France · Nalador
Hungary · Nalador
Italy · Nalador
Portugal · Nalador 500

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/6c95a31b-20e9-4214-9a1e-be51ba1a5e48
GET /v1/drugs/6c95a31b-20e9-4214-9a1e-be51ba1a5e48?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oplossing voor infusie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h08996_smpc.pdf",
  "strength": null,
  "atc_label": "Sulprostone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132971",
  "excipients": [
    "POVIDON K 17 (E 1201)",
    "TROMETAMOL",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "SULPROSTON"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132971.pdf",
  "authorised_at": "2024/04/05",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "132971//08996",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about sulproston.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console